{"id":"https://openalex.org/W2756972088","doi":"https://doi.org/10.1016/s1470-2045(17)30763-5","title":"Palbociclib plus letrozole as first-line treatment for ER-positive and HER2-negative advanced breast cancer in Chinese women: a phase 1 study","display_name":"Palbociclib plus letrozole as first-line treatment for ER-positive and HER2-negative advanced breast cancer in Chinese women: a phase 1 study","publication_year":2017,"publication_date":"2017-09-01","ids":{"openalex":"https://openalex.org/W2756972088","doi":"https://doi.org/10.1016/s1470-2045(17)30763-5","mag":"2756972088"},"language":"en","primary_location":{"id":"doi:10.1016/s1470-2045(17)30763-5","doi":"https://doi.org/10.1016/s1470-2045(17)30763-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1470-2045(17)30763-5","pdf_url":null,"source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100605683","display_name":"Huiping Li","orcid":"https://orcid.org/0000-0002-3331-647X","observed_orcids":["https://orcid.org/0000-0002-3331-647X"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huiping Li","raw_affiliation_strings":["Department of Breast Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100741380","display_name":"Qingyuan Zhang","orcid":"https://orcid.org/0000-0001-8116-5293","observed_orcids":["https://orcid.org/0000-0001-8116-5293","https://orcid.org/0000-0001-7618-4393","https://orcid.org/0000-0002-1763-9412","https://orcid.org/0000-0002-5003-8897"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qingyuan Zhang","raw_affiliation_strings":["Third Medical Department, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Third Medical Department, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100318023","display_name":"Wei Li","orcid":"https://orcid.org/0000-0001-7850-9999","observed_orcids":["https://orcid.org/0000-0001-7850-9999","https://orcid.org/0009-0003-7590-8400"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei Li","raw_affiliation_strings":["Cancer Center, The First Hospital of Jilin University, Changchun, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Hospital of Jilin University, Changchun, China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100661398","display_name":"Shusen Wang","orcid":"https://orcid.org/0000-0003-0139-5780","observed_orcids":["https://orcid.org/0000-0003-0139-5780"]},"institutions":[{"id":"https://openalex.org/I4210146711","display_name":"Sun Yat-sen University Cancer Center","ror":"https://ror.org/0400g8r85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146711"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shusen Wang","raw_affiliation_strings":["Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China","institution_ids":["https://openalex.org/I4210146711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100615992","display_name":"Ning Liao","orcid":"https://orcid.org/0000-0002-1780-5652","observed_orcids":["https://orcid.org/0000-0002-1780-5652","https://orcid.org/0000-0002-1965-9425","https://orcid.org/0000-0001-8270-9950"]},"institutions":[{"id":"https://openalex.org/I2799425052","display_name":"Guangdong General Hospital","ror":"https://ror.org/03jpekd50","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2799425052"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ning Liao","raw_affiliation_strings":["Department of Breast Surgery, Guangdong General Hospital, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Surgery, Guangdong General Hospital, Guangzhou, China","institution_ids":["https://openalex.org/I2799425052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101966522","display_name":"Peng Shen","orcid":"https://orcid.org/0000-0002-0176-127X","observed_orcids":["https://orcid.org/0000-0002-0176-127X"]},"institutions":[{"id":"https://openalex.org/I4210166576","display_name":"First Affiliated Hospital Zhejiang University","ror":"https://ror.org/05m1p5x56","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166576"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Peng Shen","raw_affiliation_strings":["Medical Oncology, The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, China","institution_ids":["https://openalex.org/I4210166576","https://openalex.org/I76130692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101518421","display_name":"Bin Shao","orcid":"https://orcid.org/0000-0001-9195-8043","observed_orcids":["https://orcid.org/0000-0001-9195-8043"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Bin Shao","raw_affiliation_strings":["Department of Breast Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101610148","display_name":"Wenhui Zhao","orcid":"https://orcid.org/0000-0002-7215-4610","observed_orcids":["https://orcid.org/0000-0002-7215-4610"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenhui Zhao","raw_affiliation_strings":["Third Medical Department, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Third Medical Department, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037686948","display_name":"Wan Sun","orcid":"https://orcid.org/0000-0002-0347-2519","observed_orcids":["https://orcid.org/0000-0002-0347-2519"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wan Sun","raw_affiliation_strings":["Clinical Pharmacology, Global Product Development, Pfizer Inc, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Global Product Development, Pfizer Inc, San Diego, CA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101819344","display_name":"Ping Yan","orcid":"https://orcid.org/0000-0003-4237-9875","observed_orcids":["https://orcid.org/0000-0003-4237-9875"]},"institutions":[{"id":"https://openalex.org/I4210148567","display_name":"Pfizer (China)","ror":"https://ror.org/04ktfyy52","country_code":"CN","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148567"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ping Yan","raw_affiliation_strings":["Clinical Statistics, Global Biometrics and Data Management, Pfizer (China) R&D Co, Ltd, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Statistics, Global Biometrics and Data Management, Pfizer (China) R&D Co, Ltd, Shanghai, China","institution_ids":["https://openalex.org/I4210148567"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039320887","display_name":"Diane Wang","orcid":"https://orcid.org/0000-0002-2290-3257","observed_orcids":["https://orcid.org/0000-0002-2290-3257"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diane Wang","raw_affiliation_strings":["Clinical Pharmacology, Global Product Development, Pfizer Inc, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Global Product Development, Pfizer Inc, San Diego, CA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Vince (Bai) Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148567","display_name":"Pfizer (China)","ror":"https://ror.org/04ktfyy52","country_code":"CN","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148567"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Vince (Bai) Li","raw_affiliation_strings":["Clinical Development, Development China Pfizer, Global Product Development, Pfizer (China) R&D Co, Ltd, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Development China Pfizer, Global Product Development, Pfizer (China) R&D Co, Ltd, Shanghai, China","institution_ids":["https://openalex.org/I4210148567"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033497592","display_name":"Carlos Linn","orcid":"https://orcid.org/0000-0001-7470-3882","observed_orcids":["https://orcid.org/0000-0001-7470-3882"]},"institutions":[{"id":"https://openalex.org/I4210148567","display_name":"Pfizer (China)","ror":"https://ror.org/04ktfyy52","country_code":"CN","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148567"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Carlos Linn","raw_affiliation_strings":["Clinical Development, Development China Pfizer, Global Product Development, Pfizer (China) R&D Co, Ltd, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Development China Pfizer, Global Product Development, Pfizer (China) R&D Co, Ltd, Shanghai, China","institution_ids":["https://openalex.org/I4210148567"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108653547","display_name":"Haihong Shi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haihong Shi","raw_affiliation_strings":["Department of Clinical Pharmacology, Clinical Assay Group, Pfizer, Inc, Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Clinical Assay Group, Pfizer, Inc, Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113966959","display_name":"Melissa T. O\u2019Gorman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa O'Gorman","raw_affiliation_strings":["Pfizer Innovative Health, Clinical Pharmacology, Pharmacometrics, Pfizer, Inc, Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Innovative Health, Clinical Pharmacology, Pharmacometrics, Pfizer, Inc, Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008098651","display_name":"Binghe Xu","orcid":"https://orcid.org/0000-0003-4195-337X","observed_orcids":["https://orcid.org/0000-0003-4195-337X","https://orcid.org/0000-0002-0234-2747","https://orcid.org/0000-0002-6863-5024"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Binghe Xu","raw_affiliation_strings":["Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China","institution_ids":["https://openalex.org/I200296433"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5008098651"],"corresponding_institution_ids":["https://openalex.org/I200296433"],"apc_list":{"value":7280,"currency":"USD","value_usd":7280},"apc_paid":null,"fwci":0.2618,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.59890167,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"18","issue":null,"first_page":"S7","last_page":"S7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/letrozole","display_name":"letrozole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.7799999713897705},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9879999756813049},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.9750000238418579},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.878000020980835},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.859000027179718},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8379999995231628},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.7089999914169312},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6449999809265137},{"id":"https://openalex.org/keywords/chinese-women","display_name":"Chinese women","score":0.593999981880188},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.5709999799728394},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.45899999141693115},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.39399999380111694},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.36399999260902405}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.9874616861343384},{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.9206724762916565},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7834765315055847},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.775792121887207},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6937218308448792},{"id":"https://openalex.org/C2777793932","wikidata":"https://www.wikidata.org/wiki/Q1116229","display_name":"Common Terminology Criteria for Adverse Events","level":3,"score":0.567140519618988},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5599589347839355},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43373411893844604},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42734047770500183},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38758936524391174},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3440307378768921},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.31321480870246887},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.18369042873382568}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1470-2045(17)30763-5","doi":"https://doi.org/10.1016/s1470-2045(17)30763-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1470-2045(17)30763-5","pdf_url":null,"source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2619542078","https://openalex.org/W3189497577","https://openalex.org/W2790211645","https://openalex.org/W2144790402","https://openalex.org/W2160494532","https://openalex.org/W3043082495","https://openalex.org/W3026119116","https://openalex.org/W2898684787","https://openalex.org/W2464376480","https://openalex.org/W2597559961"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-10-06T00:00:00"}